期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Preparation and Crystal Structure of Sarcosine 5-Nitrosalicylic Acid Organic Adduct
1
作者 金轶 车云霞 +1 位作者 魏荣敏 郑吉民 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 北大核心 2004年第11期1292-1294,共3页
The title compound (C10H12N2O7, Mr = 272.22) crystallizes in triclinic, space group P1 with a = 5.532(2), b = 9.760(4), c = 11.731(5) ?, α = 68.107(7), β = 89.179(7), γ = 77.830(7)o, V = 573.1(4) ?3, Z = 2, Dc = 1.... The title compound (C10H12N2O7, Mr = 272.22) crystallizes in triclinic, space group P1 with a = 5.532(2), b = 9.760(4), c = 11.731(5) ?, α = 68.107(7), β = 89.179(7), γ = 77.830(7)o, V = 573.1(4) ?3, Z = 2, Dc = 1.578 g/cm3, F(000) = 284 and μ(MoKa) = 0.136 mm-1. The final R = 0.0400 and wR = 0.0951 for 1468 observed reflections with I > 2σ(I). The title compound is a 1:1 adduct of sarcosine and 5-nitrosalicylic acid. The nitrogen atom of sarcosine is protonated, and the proton is from the carboxyl group of sarcosine and 5-nitrosalicylic acid with the probability of 50 percent for each. The 5-nitrosalicylic acid and sarcosine molecule of the title adduct are ABAB arranged along the c axis. There exist a lot of hydrogen bonds in the structure, linking sarcosine and 5-nitrosalicylic acid to form a three-dimensional network. 展开更多
关键词 crystal structure sarcosine 5-nitrosalicylic acid hydrogen bond PROTONATED three-dimensional network
下载PDF
Chiral resolution of N-methyl-d,l-aspartic acid using a predicted N-demethylase from Chloroflexi bacterium 54-19
2
作者 Juanjuan Du Liang Zhang 《Systems Microbiology and Biomanufacturing》 2022年第3期507-522,共16页
N-methyl-d-aspartic acid(NMDA),an amino acid existing in human and animal central nervous system,exerts agonist action on one of the glutamate receptor subtypes and is clinically used for treatment of diabetes,Parkin... N-methyl-d-aspartic acid(NMDA),an amino acid existing in human and animal central nervous system,exerts agonist action on one of the glutamate receptor subtypes and is clinically used for treatment of diabetes,Parkinson’s and Alzheimer’s syndrome.In this study,an enzymatic protocol for the chiral resolution of N-methyl-d,l-aspartic acid was built with a predicted N-demethylase(GenBank ID:OJV90073.1)from the genome of Chloroflexi bacterium 54-19.Through sequence alignment,the enzyme shares an identity of 32.19%to 2UZZ(PDB ID)with a conserved catalytic center.Recombinantly expressed in Bacillus subtilis WB600,the N-demethylase was characterized with optimal temperature and pH at 55℃and 7.5,and adaptive temperature and pH were 40-60℃ and 6-8.The effects of organic solvents and metal ions were investigated as well.Compared with other previously reported sarcosine oxidases,the enzyme showed a specific N-demethylation activity against N-methyl-l-aspartic acid according to the analysis by chiral liquid chromatography,LC-MS/MS and a detection by polarimeter.The results demonstrated 76%of 4.5 mM N-methyl-d,l-aspartic acid could be chirally separated by 7 mg·L^(−1) enzyme after reaction of 80 min.This work provided a foundation for mild synthesis of NMDA in industry. 展开更多
关键词 N-methyl-d-aspartic acid sarcosine oxidase N-DEMETHYLATION ENANTIOSELECTIVITY Kinetic resolution
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部